GSK licences global rights to linerixibat to Alfasigma in USD300m deal

IDEAYA Biosciences enrols first patient in Phase 1 trial of PRMT5 inhibitor IDE892

Halozyme reports US FDA approval of TECVAYLI in combination with DARZALEX FASPRO for relapsed/refractory multiple myeloma

Servier signs definitive agreement with Day One Biopharmaceuticals

PureHealth Research launches new natural GLP-1 supplements

PyroGenesis completes plasma torch system for Constellium aluminium furnace project

Great Novel Therapeutics' GNTbm-38 approved by US FDA for Phase I trial

Elicera Therapeutics reports complete metabolic responses in highest‑dose CARMA cohort

Johnson & Johnson reports US FDA approval of TECVAYLI plus DARZALEX FASPRO for RRMM

Thermo Fisher Scientific opens Bay Area cryo-EM Drug Discovery Center

GAIA and Daiichi Sankyo Europe partner on digital therapeutic for cardiovascular care

iLoF collaborates with Bluepharma to deploy AI-powered Optomics

Akeso agrees clinical trial collaboration with INOVIO

Airiver Medical's Airiver Pulmonary DCB receives US FDA Breakthrough Device Designation

Frontage Laboratories acquires Teddy Clinical Research Laboratory in China